[Evidence-based surgery of rectal cancer].

[1]  P. Carzaniga,et al.  Low Ligation of Inferior Mesenteric Artery in Laparoscopic Anterior Resection for Rectal Cancer Reduces Genitourinary Dysfunction: Results From a Randomized Controlled Trial (HIGHLOW Trial). , 2019, Annals of surgery.

[2]  V. Gebski,et al.  Disease-free Survival and Local Recurrence After Laparoscopic-assisted Resection or Open Resection for Rectal Cancer: The Australasian Laparoscopic Cancer of the Rectum Randomized Clinical Trial , 2019, Annals of surgery.

[3]  J. Fleshman,et al.  Disease-free Survival and Local Recurrence for Laparoscopic Resection Compared With Open Resection of Stage II to III Rectal Cancer: Follow-up Results of the ACOSOG Z6051 Randomized Controlled Trial , 2019, Annals of surgery.

[4]  H. Bonjer,et al.  Bowel Obstruction and Ventral Hernia After Laparoscopic Versus Open Surgery for Rectal Cancer in A Randomized Trial (COLOR II) , 2019, Annals of surgery.

[5]  C. Maurer,et al.  Oncological outcome after MRI‐based selection for neoadjuvant chemoradiotherapy in the OCUM Rectal Cancer Trial , 2018, The British journal of surgery.

[6]  Guoqiang Su,et al.  High ligation of the inferior mesenteric artery during sigmoid colon and rectal cancer surgery increases the risk of anastomotic leakage: a meta-analysis , 2018, World Journal of Surgical Oncology.

[7]  T. Beißbarth,et al.  Association of Plane of Total Mesorectal Excision With Prognosis of Rectal Cancer: Secondary Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trial , 2018, JAMA surgery.

[8]  I. Endo,et al.  Randomized clinical trial of high versus low inferior mesenteric artery ligation during anterior resection for rectal cancer , 2018, BJS open.

[9]  G. Beets,et al.  Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study , 2018, The Lancet.

[10]  R. Perez,et al.  Oncological and Survival Outcomes in Watch and Wait Patients With a Clinical Complete Response After Neoadjuvant Chemoradiotherapy for Rectal Cancer: A Systematic Review and Pooled Analysis , 2018, Annals of surgery.

[11]  Guiying Wang,et al.  High tie versus low tie of the inferior mesenteric artery in colorectal cancer: A meta-analysis. , 2018, International journal of surgery.

[12]  T. Hothorn,et al.  Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal Cancer , 2017, Journal of the National Cancer Institute.

[13]  S. Balyasnikova,et al.  How Should Imaging Direct/Orient Management of Rectal Cancer? , 2017, Clinics in Colon and Rectal Surgery.

[14]  H. Yamaue,et al.  Oncological Outcomes following Rectal Cancer Surgery with High or Low Ligation of the Inferior Mesenteric Artery , 2017, Gastrointestinal Tumors.

[15]  H. Nelson,et al.  Evidence in Favor of Standard Surgical Treatment for Rectal Cancer , 2017, JAMA oncology.

[16]  N. Baxter,et al.  A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis. , 2017, The lancet. Gastroenterology & hepatology.

[17]  C. Schroeder,et al.  Organ preservation in rectal cancer – Challenges and future strategies , 2017, Clinical and translational radiation oncology.

[18]  R. Ramsay,et al.  Outcome and Salvage Surgery Following “Watch and Wait” for Rectal Cancer after Neoadjuvant Therapy: A Systematic Review , 2017, Diseases of the colon and rectum.

[19]  L. Stassen,et al.  Long-term Outcome of an Organ Preservation Program After Neoadjuvant Treatment for Rectal Cancer. , 2016, Journal of the National Cancer Institute.

[20]  C. Rödel,et al.  Rectal cancer: Neoadjuvant chemoradiotherapy. , 2016, Best practice & research. Clinical gastroenterology.

[21]  S. Balyasnikova,et al.  Optimal Imaging Strategies for Rectal Cancer Staging and Ongoing Management , 2016, Current Treatment Options in Oncology.

[22]  T. Beißbarth,et al.  Stage-Dependent Frequency of Lymph Node Metastases in Patients With Rectal Carcinoma After Preoperative Chemoradiation: Results from the CAO/ARO/AIO-94 Trial and From a Comparative Prospective Evaluation With Extensive Pathological Workup , 2016, Diseases of the colon and rectum.

[23]  P. Quirke,et al.  Prospective Validation of a Low Rectal Cancer Magnetic Resonance Imaging Staging System and Development of a Local Recurrence Risk Stratification Model: The MERCURY II Study , 2016, Annals of surgery.

[24]  R. Ramsay,et al.  Predicting pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review , 2016, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[25]  V. Gebski,et al.  Effect of Laparoscopic-Assisted Resection vs Open Resection on Pathological Outcomes in Rectal Cancer: The ALaCaRT Randomized Clinical Trial. , 2015, JAMA.

[26]  L. Stassen,et al.  Assessment of Clinical Complete Response After Chemoradiation for Rectal Cancer with Digital Rectal Examination, Endoscopy, and MRI: Selection for Organ-Saving Treatment , 2015, Annals of Surgical Oncology.

[27]  J. Rosenberg,et al.  Extralevatory abdominoperineal excision (ELAPE) does not result in reduced rate of tumor perforation or rate of positive circumferential resection margin: a nationwide database study. , 2015, Annals of surgery.

[28]  J. Garcia-Aguilar,et al.  Advances and challenges in treatment of locally advanced rectal cancer. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  Jacob Rosenberg,et al.  A randomized trial of laparoscopic versus open surgery for rectal cancer. , 2015, The New England journal of medicine.

[30]  H. Yamaue,et al.  Randomized clinical trial of defaecatory function after anterior resection for rectal cancer with high versus low ligation of the inferior mesenteric artery , 2015, The British journal of surgery.

[31]  Stanley T. Yu,et al.  MR imaging for rectal cancer: the role in staging the primary and response to neoadjuvant therapy , 2014, Expert review of gastroenterology & hepatology.

[32]  E. Haglind,et al.  Extralevator abdominoperineal excision (ELAPE) for rectal cancer—short-term results from the Swedish Colorectal Cancer Registry. Selective use of ELAPE warranted , 2014, International Journal of Colorectal Disease.

[33]  E. Haglind,et al.  Patient-reported genitourinary dysfunction after laparoscopic and open rectal cancer surgery in a randomized trial (COLOR II) , 2014, The British journal of surgery.

[34]  S. le Cessie,et al.  Differences in Circumferential Resection Margin Involvement After Abdominoperineal Excision and Low Anterior Resection No Longer Significant , 2014, Annals of surgery.

[35]  H. Ortiz,et al.  Multicentre propensity score‐matched analysis of conventional versus extended abdominoperineal excision for low rectal cancer , 2014, The British journal of surgery.

[36]  J. Park,et al.  Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial. , 2014, The Lancet. Oncology.

[37]  T. Beißbarth,et al.  Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO/ARO/AIO-94 trial. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  J. Gama-Rodrigues,et al.  Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control. , 2014, International journal of radiation oncology, biology, physics.

[39]  M. Kalady,et al.  Clinical Criteria Underestimate Complete Pathological Response in Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy , 2014, Diseases of the colon and rectum.

[40]  Hui Peng,et al.  Comparison of short- and long-term outcomes after extralevator abdominoperineal excision and standard abdominoperineal excision for rectal cancer: a systematic review and meta-analysis , 2014, International Journal of Colorectal Disease.

[41]  J. Stoker,et al.  Patients who undergo preoperative chemoradiotherapy for locally advanced rectal cancer restaged by using diagnostic MR imaging: a systematic review and meta-analysis. , 2013, Radiology.

[42]  S. Laurberg,et al.  Impact of bowel dysfunction on quality of life after sphincter‐preserving resection for rectal cancer , 2013, The British journal of surgery.

[43]  E. Haglind,et al.  Health-related quality of life after laparoscopic and open surgery for rectal cancer in a randomized trial , 2013, The British journal of surgery.

[44]  W. Hop,et al.  Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. , 2013, The Lancet. Oncology.

[45]  A. Rogers,et al.  Multicentre study of circumferential margin positivity and outcomes following abdominoperineal excision for rectal cancer , 2013, The British journal of surgery.

[46]  T. Saclarides,et al.  Tumor Scatter After Neoadjuvant Therapy for Rectal Cancer: Are We Dealing with an Invisible Margin? , 2012, Diseases of the colon and rectum.

[47]  C. Knowles,et al.  Anterior resection syndrome. , 2012, The Lancet. Oncology.

[48]  R. Glynne-Jones,et al.  Critical appraisal of the ‘wait and see’ approach in rectal cancer for clinical complete responders after chemoradiation , 2012, The British journal of surgery.

[49]  K. Sheahan,et al.  The surgical significance of residual mucosal abnormalities in rectal cancer following neoadjuvant chemoradiotherapy , 2012, The British journal of surgery.

[50]  J. Gama-Rodrigues,et al.  Role of biopsies in patients with residual rectal cancer following neoadjuvant chemoradiation after downsizing: can they rule out persisting cancer? , 2012, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[51]  J. Gaedcke,et al.  The molecular basis of chemoradiosensitivity in rectal cancer:implications for personalized therapies , 2012, Langenbeck's Archives of Surgery.

[52]  Joseph Beyene,et al.  Diagnostic Accuracy of MRI for Assessment of T Category, Lymph Node Metastases, and Circumferential Resection Margin Involvement in Patients with Rectal Cancer: A Systematic Review and Meta-analysis , 2012, Annals of Surgical Oncology.

[53]  Geerard L Beets,et al.  Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[54]  B. Nordlinger,et al.  Where does pelvic nerve injury occur during rectal surgery for cancer? , 2011, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[55]  Gina Brown,et al.  Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[56]  H. Witzigmann,et al.  Extended abdominoperineal excision vs. standard abdominoperineal excision in rectal cancer—a systematic overview , 2011, International Journal of Colorectal Disease.

[57]  G. Beets,et al.  Local staging of rectal cancer: A review of imaging , 2011, Journal of magnetic resonance imaging : JMRI.

[58]  Gina Brown,et al.  Preoperative High-resolution Magnetic Resonance Imaging Can Identify Good Prognosis Stage I, II, and III Rectal Cancer Best Managed by Surgery Alone: A Prospective, Multicenter, European Study , 2011, Annals of surgery.

[59]  J. Park,et al.  Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. , 2010, The Lancet. Oncology.

[60]  P. Quirke,et al.  Multicentre experience with extralevator abdominoperineal excision for low rectal cancer , 2010, The British journal of surgery.

[61]  Gina Brown,et al.  Magnetic Resonance Imaging Prediction of an Involved Surgical Resection Margin in Low Rectal Cancer , 2009, Diseases of the colon and rectum.

[62]  J. Monson,et al.  Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial , 2009, The Lancet.

[63]  M. DeRuiter,et al.  Causes of fecal and urinary incontinence after total mesorectal excision for rectal cancer based on cadaveric surgery: a study from the Cooperative Clinical Investigators of the Dutch total mesorectal excision trial. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[64]  P. Quirke,et al.  Evidence of the oncologic superiority of cylindrical abdominoperineal excision for low rectal cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[65]  M. Konerding,et al.  How to Optimize Autonomic Nerve Preservation in Total Mesorectal Excision: Clinical Topography and Morphology of Pelvic Nerves and Fasciae , 2008, World Journal of Surgery.

[66]  Phil Quirke,et al.  What is the role for the circumferential margin in the modern treatment of rectal cancer? , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[67]  D. Jayne,et al.  Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[68]  A. Norman,et al.  Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study. , 2007, Radiology.

[69]  T. Häggmark,et al.  Extended abdominoperineal resection with gluteus maximus flap reconstruction of the pelvic floor for rectal cancer , 2007, The British journal of surgery.

[70]  J. Gama-Rodrigues,et al.  Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy , 2006, Journal of Gastrointestinal Surgery.

[71]  P. D. Peppercorn,et al.  Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study , 2006, BMJ : British Medical Journal.

[72]  P. Quirke,et al.  The Modern Abdominoperineal Excision: The Next Challenge After Total Mesorectal Excision , 2005, Annals of surgery.

[73]  M. Mazumdar,et al.  Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate end point. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[74]  Philip Quirke,et al.  Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial , 2005, The Lancet.

[75]  Rainer Fietkau,et al.  Preoperative versus postoperative chemoradiotherapy for rectal cancer. , 2004, The New England journal of medicine.

[76]  Fábio Guilherme Campos,et al.  Operative Versus Nonoperative Treatment for Stage 0 Distal Rectal Cancer Following Chemoradiation Therapy: Long-term Results , 2004, Annals of surgery.

[77]  I. Nagtegaal,et al.  Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[78]  H. Putter,et al.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. , 2001, The New England journal of medicine.

[79]  L Påhlman,et al.  Improved survival with preoperative radiotherapy in resectable rectal cancer. , 1997, The New England journal of medicine.

[80]  R. Heald,et al.  RECURRENCE AND SURVIVAL AFTER TOTAL MESORECTAL EXCISION FOR RECTAL CANCER , 1986, The Lancet.

[81]  C. Marijnen,et al.  Organ preservation in rectal cancer: have all questions been answered? , 2015, The Lancet. Oncology.

[82]  Daniel J Sargent,et al.  Effect of Laparoscopic-Assisted Resection vs Open Resection of Stage II or III Rectal Cancer on Pathologic Outcomes: The ACOSOG Z6051 Randomized Clinical Trial. , 2015, JAMA.

[83]  M. Kreis,et al.  Use of Preoperative Magnetic Resonance Imaging to Select Patients with Rectal Cancer for Neoadjuvant Chemoradiation—Interim Analysis of the German OCUM Trial (NCT01325649) , 2015, Journal of Gastrointestinal Surgery.

[84]  Gina Brown,et al.  Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-year follow-up results of the MERCURY study. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[85]  C. Velde,et al.  Urinary and sexual dysfunction after rectal cancer treatment , 2011, Nature Reviews Urology.

[86]  I. Nagtegaal,et al.  Low rectal cancer: a call for a change of approach in abdominoperineal resection. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.